Janssen Search
Search results
Neil Davie, Ph.D.
NEIL DAVIE, Ph.D. HEAD, LATE DEVELOPMENT CARDIOVASCULAR, METABOLISM & PULMONARY HYPERTENSION Neil Davie, Ph.D. is the Head, Late Development, of Cardiovascular, Metabolism, & Pulmonary Hypertension (CVM & PH). He has extensive experience as a ...
Wim Parys, M.D.
Wim Parys, M.D., obtained his medical degree from the Katholieke Universiteit Leuven, Belgium. He was in private practice for nine years before joining the Janssen Research Foundation in Beerse, Belgium, where he held several R&D positions and ...
Opening Vaccines Launch Facility speakers
Oct 24, 2018 Speakers Inspiring and engaging presentations and panal discussions will hightlight why it is important to "invest locally, to protect globally". View the complete program of the symposium. Moderator Guest speakers/panelists ...
Justin Scheer, Ph.D.
JUSTIN SCHEER, Ph.D. VICE PRESIDENT GENE THERAPY AND GENE DELIVERY PLATFORMS Justin Scheer, Ph.D. is Vice President of Gene Therapy and Gene Delivery Platforms for Janssen BioTherapeutics (JBIO), the biotherapeutics engine of Janssen Research & ...
Avrum Spira, M.D., M.Sc.
AVRUM SPIRA, M.D., M.Sc. GLOBAL HEAD LUNG CANCER INITIATIVE AT JOHNSON & JOHNSON AND WORLD WITHOUT DISEASE ACCELERATOR Avrum “Avi” Spira, M.D., M.Sc. is the Global Head of Johnson & Johnson’s cross-sector Lung Cancer Initiative (LCI). The vision ...
Pamela Carroll, Ph.D.
Pamela Carroll, Ph.D. is Vice President of Oncology Scientific Innovation at Janssen Research & Development, LLC. She represents the Oncology Therapeutic Area in Johnson & Johnson Innovation, Boston and is responsible for leading partnerships and ...
Pamela Carroll, Ph.D.
Pamela Carroll, Ph.D. is Vice President of Oncology Scientific Innovation at Janssen Research & Development, LLC. She represents the Oncology Therapeutic Area in Johnson & Johnson Innovation, Boston and is responsible for leading partnerships and ...
Joseph Hedrick, Ph.D.
JOSEPH HEDRICK, PH.D. HEAD, TYPE 1 DIABETES VENTURE WORLD WITHOUT DISEASE ACCELERATOR As Head of the Type 1 Diabetes (T1D) Venture within the World Without Disease Accelerator (WWDA), Joe leads efforts utilizing the rapidly emerging science of immune ...
Michelle Kramer, M.D., M.P.H.
MICHELLE KRAMER, M.D., M.P.H. GLOBAL HEAD OF DEVELOPMENT Michelle Kramer, M.D., M.P.H. is the Global Head of Development for Neuroscience at Janssen Research & Development. With more than two decades of experience at Janssen and Johnson & Johnson, ...
Dan Baker, M.D.
Dan Baker, M.D. joined the Janssen Pharmaceutical Companies of Johnson & Johnson through Centocor Research & Development in 2000 following an 18-year academic career at the University of Pennsylvania in Philadelphia, Pennsylvania. Since joining ...